Vanda Pharmaceuticals Earnings: Here’s Why the Stock is Down Now
Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 2.33%.
Vanda Pharmaceuticals, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased to $-0.11 in the quarter versus EPS of $-0.28 in the year-earlier quarter.
Revenue: Decreased 0.72% to $8.32 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Vanda Pharmaceuticals, Inc. reported adjusted EPS loss of $0.11 per share. By that measure, the company beat the mean analyst estimate of $-0.22. It missed the average revenue estimate of $8.43 million.
Key Stats (on next page)…